PMGC Holdings (ELAB) Gross Profit (2022 - 2026)
PMGC Holdings (ELAB) posted Gross Profit of $230474.0 for Q1 2026, up 114.83% sequentially from $107284.0 in Q4 2025, and up 89.14% YoY from $121851.0 in Q1 2025.
PMGC Holdings (ELAB) Gross Profit (2022 - 2026) Analysis & Trends
PMGC Holdings has reported Gross Profit for 5 years, with the latest figure at $230474.0 in Q1 2026.
- Quarterly Gross Profit rose 89.14% year-over-year to $230474.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $415788.0 (down 71.78% YoY) and the FY2025 annual result came in at $185314.0, down 89.69% from the prior year.
- Gross Profit advanced to $230474.0 in Q1 2026 per ELAB's latest filing, from $107284.0 in the prior quarter.
- Over five years, Gross Profit peaked at $237.7 million in Q3 2022 and troughed at -$353.5 million in Q4 2022.
- A 5-year average of -$8.0 million and a median of $298309.5 in 2023 frame the typical range for Gross Profit.
- The sharpest annual moves came in 2023 and 2024: Gross Profit tumbled 99.85% in 2023, then surged 352.96% in 2024.
- Over 5 years, Gross Profit stood at -$353.5 million in 2022, then jumped by 100.13% to $461698.0 in 2023, then gained by 12.26% to $518294.0 in 2024, then slumped by 79.3% to $107284.0 in 2025, then jumped by 114.83% to $230474.0 in 2026.
- According to Business Quant data, Gross Profit over the past three periods registered $230474.0, $107284.0, and $78030.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | PMGC Holdings | 31.22 Mn | 12.43 Mn | 385,691.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 230,474.00 |
| Mar 31, 2026 | 230,474.00 |
| Dec 31, 2025 | 107,284.00 |
| Dec 31, 2025 | 107,284.00 |
| Sep 30, 2025 | 78,030.00 |
| Sep 30, 2025 | 78,030.00 |
| Mar 31, 2025 | 121,851.00 |
| Mar 31, 2025 | 121,851.00 |
| Dec 31, 2024 | 518,294.00 |
| Dec 31, 2024 | 518,294.00 |
| Sep 30, 2024 | 393,899.00 |
| Sep 30, 2024 | 393,899.00 |
| Jun 30, 2024 | 439,256.00 |
| Jun 30, 2024 | 439,256.00 |
| Mar 31, 2024 | 445,652.00 |
| Mar 31, 2024 | 445,652.00 |
| Dec 31, 2023 | 461,698.00 |
| Dec 31, 2023 | 461,698.00 |
| Sep 30, 2023 | 366,145.00 |
| Sep 30, 2023 | 366,145.00 |